Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-31

Clinical Trial Update: Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating a chromium and metformin combination in Type 2 Diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium (Chromium)
  • metformin (metformin)

Snippet

Sponsor: Bastyr University | Conditions: Type 2 Diabetes | Phase 1 | Status: TERMINATED